Precise Treatments. Real-World Impact.
Innovating tumor- and tissue-specific prodrugs with desired functionality
Vibrant Therapeutics develops conditional activation and targeted delivery multispecific antibody-based prodrugs. Our research focuses on developing life-saving biotherapeutics for patients with oncological, autoimmune, and neurological diseases.
Pipeline
Vibrant’s approach for rational design of biotherapeutics
We unlock the secrets of proteins to design new biotherapeutics with targeted functions and improved qualities.
Vibrant BumbleBee platform combines advanced computing and multi-specific antibody engineering to streamline the discovery process. This one-stop solution helps us create safer, more effective, and higher-quality biotherapeutics.
Vibrant LogicBee platform uses cutting-edge proteomics analysis to identify key proteins that differ between healthy and diseased tissues. This paves the way for designing biotherapeutics that precisely target diseases.
Vibrant NeuroBee platform enables efficient delivery across the brain-blood-barrier using a unique technology. This unleashes the power of our biotherapeutics for CNS disease treatment.
Partner With Us
We are open to partnerships and collaborations regarding our assets and technologies.
Please contact us at BD@vibrantx.io.
Team
Dr. Larry Wang
Co-CEO & CTODr. Han Lee
Co-CEOLili Huang
VP, OperationsDr. Oliver Zhang
SVP, Antibody DiscoveryDr. Liang Deng
SVP, CMCDr. Leon Wert-Lamas
BD LeadBy elucidating key relationships between protein sequences, 3D structures, and therapeutic functions, Vibrant Therapeutics has paved the way for the design of revolutionary biotherapeutics to address unmet medical needs.
Larry Wang, Ph.D.
Co-CEO & CTOVibrant drug discovery platform goes beyond early-stage biomolecule design. It also considers late-stage druggability and manufacturability, ensuring efficient development throughout the entire process.
Liang Deng, Ph.D.
SVP, CMCOur technologies allowed us to predict and test a vast amount of compound variants with unparalleled efficiency and accuracy, leading to a next-generation of more efficacious and safer drugs for patients in need.
Oliver Zhang, Ph.D.
SVP, Antibody DiscoveryJoin Us
Vibrant Therapeutics seeks passionate business and scientific leaders to join our team in the US or China. We offer the opportunity to create a positive impact on patients' lives.